PTI stresses benefits of non-destructive testing at Interphex
in-Pharmatechnologist.com spoke with PTI's Oliver Stauffer at Interphex in New York, US who explained that the new testing technology - the Veripack 410 – brings together a unique combination of methodologies.
“It uses both vacuum decay and forced load technology to detect microleaks as small as 10 microns in blister packaging… Most methods out there are destructive and do not rely on quantitative test results and so do not have repeatability.”
Stauffer went on to say that each test takes around 15 seconds and can examine six blister packs at the same time, which he suggested could generate significant cost and time savings for manufacturers.
“If you have a class II drug that is expensive and very costly to dispose of this methods does not require that kind of disposal and you can return the product to the production line and there’s a very high amount of savings associated with that.”
He also predicted that impending changes to USP 1207 – which relates to sterile product packaging integrity – will drive demand for quantitative analysis methods.